Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography
Authors:
- Masatomo MiuraMMMasatomo Miura
- Tsukasa UnoTUTsukasa Uno
- Tomonori TateishiTTTomonori Tateishi
- Toshio SuzukiTSToshio Suzuki
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (2) , 741-745
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 2004
- The effect of rifampin administration on the disposition of fexofenadineClinical Pharmacology & Therapeutics, 2001
- OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of FexofenadineDrug Metabolism and Disposition, 1999
- Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16 455) and its enantiomers in healthy male volunteersBiopharmaceutics & Drug Disposition, 1998
- A Sensitive HPLC Method for the Determination of Terfenadine and Its Metabolite in Human PlasmaJournal of Liquid Chromatography, 1994
- Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic StudiesPharmaceutical Research, 1992
- Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1991